COSMO BIO COMPANY, LIMITEDJP:3386Income statement

Market cap
¥7.9B
P/E ratio
17.2x
2011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Revenue7,1927,2417,0507,2357,3577,4277,0687,2617,5908,0929,2319,5539,34010,037
Cost of revenue---4,8114,9764,6554,5354,6024,7104,9405,5726,1126,0906,708
Gross profit---2,4242,3802,7722,5322,6592,8793,1523,6583,4403,2493,329
Gross margin (%)---
Operating expenses ---2,2612,1802,2572,3392,3302,4742,3992,6092,6242,7293,010
Operating income ---1622005141933284057521,048816519318
Income before tax 8568014442853734833974034708171,099790653364
Provision for income taxes---13115817914912514230733023819199
Net income 458411313201230276250278246701768552461269
Earnings per share76.5269.4452.8234.0238.8942.9340.1543.9340.14113.7126.9489.1375.9745.05
Dividend per share2,0002,000202016181414143436363050